Viewing Study NCT05211167


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2025-12-25 @ 10:45 PM
Study NCT ID: NCT05211167
Status: UNKNOWN
Last Update Posted: 2022-01-27
First Post: 2022-01-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module